�����Ƶ

Brain health and neuroplasticity. 

A neuroscientist with training in neurology I have been studying brain functions and neuroplasticity in health and disease for 30 years. I am particularly interested in the neurobiological mechanisms of emotional-affective and cognitive aspects of disorders such as chronic pain, comorbid neuropsychiatric disorders, and neurodegenerative diseases. The analysis of emotional-affective and cognitive brain mechanisms of pain centered on the amygdala and cortico-limbic interactions is a key contribution of our work to the field of pain research and neuroscience. Our current focus on neuroimmune signaling in the brain is pioneering the analysis of neuroplasticity in pain and comorbid disorders. 

I have been able to initiate, facilitate and lead collaborative basic science projects and studies in humans on mechanisms, biomarkers and interventions for pain, aging-related health issues, including mental health and dementias and Alzheimer's disease in particular, and other disorders in my roles as Department Chair, Founding Director of the Center of Excellence for Translational Neuroscience and Therapeutics (CTNT), and Executive Director and Chief Scientific Officer of the Garrison Institute on Aging (GIA). As the GIA Director I also oversee Project FRONTIER, a longitudinal epidemiological study on aging and cognitive decline in a multi-ethnic sample of adults in rural communities. The GIA houses a brain bank with more than 200 frozen and fixated brains from patients with various forms of dementia and controls, which we have developed as a valuable resource for research collaborations. Our basic research program explores brain mechanisms of neurological and psychiatric disorders, using a multidisciplinary approach of state-of-the-art in vivo and in vitro electrophysiology, multi-photon imaging in vivo and ex vivo, microendoscopy for in vivo calcium imaging, optogenetics, chemogenetics, viral vector strategies, transgenics, molecular biology, immunohistochemistry, (opto-)pharmacology, and innovative behavioral assays. Collaborative studies in humans explore biomarkers and interventions in chronic pain and aging-related health issues such as dementias and Alzheimer's disease in particular, include programs to improve the mental health of informal caregivers of patients with Alzheimer’s Disease and Alzheimer’s Disease Related Dementias.

My work has been published in more than 170 research and review articles and presented in nearly 160 invited lectures and workshops. My nationally and internationally recognized (h-index 66, 13462 citations, Google Scholar, 05-02-24) research program has been continuously funded by NIH since 1999 and by USDA and foundations. The overall goal of our translational research is the better understanding of mechanisms of neurological and psychiatric disorders to identify novel targets for new and improved diagnostic and therapeutic strategies.

Another important goal is the education and training of biomedical researchers and health care professionals. I have a track record of successfully mentoring junior faculty, postdoctoral fellows, clinical residents, MD/PhD students, PhD students, MD/MS students, medical students, and undergraduate students. Generation and dissemination of knowledge about brain health is an important goal and benefit to medical school education and graduate and postgraduate training.

CURRENT FUNDING: 

• USDA/NIFA, 2023-08169 - “Ginger and the microbiota-gut-brain connection in sciatic pain individuals”, MPI, Volker Neugebauer
• Garrison Family Foundation- “Innovative mental health services, recreational intervention, and imaging-based biomarker screening for AD/ADRD patients and caregivers”, PI, Volker Neugebauer
• Sabinsa Corporation, NJ - “Curcumin and Retinal Amyloid-beta Pilot Study”, PI, Leslie Shen
• NIH/NINDS, R01 NS129552 - “Brain Circuits of Migraine Pain”
  MPI, Volker Neugebauer
• �����Ƶ SOM, CTNT, GIA Seed Fund Program- “Mental Health Telemedicine for Caregivers of People with Alzheimer’s’ Disease and Related Dementias in Rural West Texas”, PI, Volker Neugebauer
• SOM Davis Foundation- “Ginger extract in anxio-depressive disorders: gut-brain-axis”, MPI, Volker Neugebauer
• Diversity, Equity and Inclusion (DEI) research grant- “Implementing Individual Mental Health Treatment and Respite for Hispanic Informal Caregivers of Individuals with Dementia”, MPI, Volker Neugebauer 
• Garrison Family Foundation- “Increasing Mental Health Services for Low Income and Minority Informal Caregivers of Dementia Patients: A GIA and TTU Collaboration”, PI, Volker Neugebauer
• NIH/NINDS, R01 NS120395 - " A prolactin-mediated neuroendocrine link between stress-induced latent sensitization and female-selective pain", MPI, Volker Neugebauer
• USDA/NIFA, 2021-67017-34026 - "Ginger root extract for neuropathic pain" 
  MPI, Volker Neugebauer
• NIH/NINDS, R01 NS118731 - "Trans-Synaptic Signaling Complex in Amygdala Pain Mechanisms" 
  MPI, Volker Neugebauer
• NIH/NINDS, R01 NS109255 - "Pronociceptive and antinociceptive opioid mechanisms in the central nucleus of the Amygdala",
  Co-I, Volker Neugebauer
• NIH/NINDS, R01 NS038261 - “Amygdala Pain Mechanisms”
  PI, Volker Neugebauer